Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Normal Saline

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Withdrawn1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT03959553Phase 2WithdrawnPrimary

GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)

NCT00423228Not ApplicableCompletedPrimary

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Showing all 2 trials

Research Network

Common Treatments

  • Normal Saline1
  • Donepezil1
  • Zt11
  • Gv10011

Active Sponsors

  • Debiopharm International SA1
  • GemVax & Kael1

Top Investigators

Activity Timeline